Actinium Pharmaceuticals Announces Actimab-A Intellectual Property and Manufacturing Advances and Provides NYSE American Listing Update

Go back to Actinium Pharmaceuticals Announces Actimab-A Intellectual Property and Manufacturing Advances and Provides NYSE American Listing Update
Actinium Pharmaceuticals, Inc. (NYSE: ATNM) Delayed: 1.03 -0.02 (1.9%)
Previous Close $1.05    52 Week High $3.50 
Open $1.05    52 Week Low $0.86 
Day High $1.06    P/E N/A 
Day Low $1.02    EPS $-7.61 
Volume 54,230